A look in the mirror

Journal of Clinical Oncology

Volumn 27, Issue 8, 2009, Pages 1158-1159

  McLaughlin, Peter ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

BONE MARROW; CANCER STAGING; CLINICAL RESEARCH; EDITORIAL; EUROPE; FOLLICULAR LYMPHOMA; GEOGRAPHIC DISTRIBUTION; HUMAN; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RADIOIMMUNOTHERAPY;

BONE MARROW EXAMINATION; CLINICAL TRIALS AS TOPIC; HUMANS; LYMPHOMA, FOLLICULAR; NEOPLASM STAGING;

EID: 62549127758     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.19.8655     Document Type: Editorial

References (16)

1. Feugier P, Van Hoof A, Sebban C, et al: Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: A study by the Groupe d'Etude des Lymphomes de I'Adulte. J Clin Oncol 23:4117-1126, 2005
2. Friedberg JW, Taylor MD, Cerhan JR, et al: Follicular lymphoma in the United States: First report of the National LymphoCare Study. J Clin Oncol 27:1202-1208, 2009
3. Zelenetz AD, Advani RH, Byrd JC, et al: Non-Hodgkin's lymphomas. Journal of the Natl Compr Cane Netw 6:356-21, 2008
4. Dreyling M, Fetscher S, Kornek P, et al: Treatment of indolent non-Hodgkin's lymphoma in Germany: Results of a representative population-based survey. Blood 110:407a, 2007 (suppl; abstr 1353)
5. Solal-Celigny P, Roy P, Colombat P, etal: Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004
6. Shipp MA, Harrington DP, Anderson JR, et al: A predictive model for aggressive non-Hodkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
7. Solal-Celigny P: International prognostic index for follicular lymphomas. Proc Am Soc Clin Oncol 21:281a, 2002 (suppl; abstr 1121)
8. Federico M, Bellei M, Marcheselli L, et al: F2 prognostic index. Ann Oncol 19:101-102, 2008 (suppl 4; abstr 058)
9. Press OW, Unger JM, Braziel RM, et al: Phase II trial of CHOP chemo-therapy followed by tositumomab/iodine 1-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: Five-year follow-up of Southwest Oncology Group Protocol S9911. J Clin Oncol 24:4143-4149, 2006
10. 90Y- lbritumomab tiuxetan consolidation of first remission in advanced stage follicular non-Hodgkin's lymphoma: First results of the international randomized phase 3 first-line indolent trial in 414 patients. Blood 110:198a, 2007 (suppl; abstr 643)
11. Wahlin BE, Sander B, Christensson B, et al: Grading follicular lymphoma:No difference between 1,2 and 3a, but 3b is something else. Blood 110:768a,2007 (suppl; abstr 2611)
12. Hehn ST, Grogan TM, Miller TP: Utility of fine-needle aspirations as a diagnostic technique in lymphoma. J Clin Oncol 22:3046-3052, 2004
13. Peterson PM, Gospodarowicz M, Tsang R, et al: Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. Proc Am Soc Clin Oncol 22:561, 2004 (suppl; abstr 6521)
14. Seymour JF, Pro B, Fuller LM, et al: Long-term follow-up of a prospective study of combined modality therapy for stage l-ll indolent non-Hodgkin's lymphoma. J Clin Oncol 21:2115-2122, 2003
15. 0 follicular lymphoma? A study of 43 consecutive patients in a single center. Ann Oncol 7:713-718, 1996
16. Rigacci L, Federico M, Martelli M, et al: The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: Retrospective study of the Intergrupo Italiano Linformi on 761 cases. Leuk Lymphoma 44:1911-1917, 2003